# A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects

> **NCT07671833** · PHASE1 · COMPLETED · sponsor: **Luye Pharma Group Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** LY03015 (LPM3770164 extended-release tablets)

## Key facts

- **NCT ID:** NCT07671833
- **Lead sponsor:** Luye Pharma Group Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-04-15
- **Primary completion:** 2026-05-08
- **Final completion:** 2026-05-27
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2026-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07671833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07671833, "A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07671833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*